💊 Health Alert
⚠️ March 2026
Updated March 12, 2026
⏱ 10 Min Read
Iran War Impact on Medicine Prices in India 2026
Will Your Medicines Get Costlier? — Full Explainer
This is serious news for every Indian family. The Iran war has pushed pharma raw material costs up by 30–60% in just two weeks. Shipping costs have doubled. Container ships are scarce. Key ingredients like glycerine, paracetamol base, and pharma solvents are getting expensive. India imports most of its drug ingredients (APIs) from China — through routes that pass close to the conflict zone. Medicines you buy daily may soon cost more. Here is the full picture.
30–60%
Rise in Key Raw Material Costs
₹5,000 Cr
Pharma Export Losses Feared
$4K–$8K
Extra Surcharge per Shipment
10–15 Days
Before Stock Runs Out (Industry Warning)
📌 Direct Answer — Iran War & Medicine Prices India 2026
Will medicines get costlier in India because of the Iran war?
Yes — and the process has already started. The Iran war disrupted global shipping routes. Container ships are now scarce and freight costs have doubled. India imports most of its pharma raw materials from China through these very routes. Key ingredients like glycerine, paracetamol base, and pharma solvents have risen 20–64% in just two weeks. Pharmexcil, India’s pharma export body, has warned of losses up to ₹5,000 crore. Vitamins, antibiotics, painkillers, and solvents are most at risk. Medicines for diabetes, blood pressure, and cancer could also be affected if the conflict continues.
💊 What Is Happening Right Now — The Full Story
On February 28, 2026, the US and Israel launched strikes on Iran. The conflict disrupted the Strait of Hormuz — one of the world’s most important shipping corridors. About 50% of India’s oil and 80% of its natural gas flow through this strait. However, the impact does not stop at fuel.
Ships now take longer routes. Insurance costs have risen. Port surcharges have jumped steeply too. Freight charges have doubled. Every shipment of pharma ingredients now costs $4,000 to $8,000 more than before.
So India’s drug makers are now absorbing these higher costs. This hurts their profits. Small companies face the most pain. Many cannot raise prices immediately. The government controls drug prices. However, if the crisis continues for another 10–15 days, industry experts warn that raw material stocks will run out. At that point, the impact on medicine availability and prices becomes unavoidable.
Before War
Stable raw material prices · Normal freight costs · Regular China-India API shipments · Adequate stock levels
After Iran War
Raw materials up 30–64% · Freight costs doubled · Surcharges of $4K–$8K per shipment · Stocks at risk in 10–15 days
💡 Key Fact: India is the world’s largest supplier of generic medicines — often called the “pharmacy of the world.” Over 40% of the generic drugs used in the USA come from India. So this crisis affects not just Indian patients — it affects millions globally.
📊 3 Key Facts You Must Know
🇨🇳
India Depends on China for APIs
India imports the majority of its drug ingredients (APIs) from China. These are the core building blocks of every medicine. No API means no tablet, no capsule, no syrup. Without them, Indian factories cannot produce drugs. The China-to-India shipping route passes through waters affected by the Iran conflict.
⏱️
Just-in-Time Stocks — High Risk
Indian pharma companies use “just-in-time” inventory. This means they keep minimal stock — usually enough for only 2–4 weeks. A 10–15 day delay stops production. Factories cannot make medicines without raw materials. This system works well normally. But it fails fast in a crisis.
📋
NPPA Controls Most Drug Prices
The National Pharmaceutical Pricing Authority controls the prices of essential medicines in India. Pharma companies cannot simply raise prices on regulated drugs. So they are currently absorbing the higher costs. However, the industry is already asking the government to allow emergency price revisions.
🛢️ Root Causes
Why Is the Iran War Raising Medicine Prices?
The connection between an Iran war and your medicine price at the local chemist is not obvious. So here is the step-by-step chain of events — explained simply.
01
🚢 Strait of Hormuz Gets Disrupted
The war disrupted the Strait of Hormuz — the narrow waterway between Iran and Oman. Nearly 20% of global maritime trade passes through this strait. Ships now avoid the area or take much longer alternative routes. As a result, shipping times increase and freight costs surge dramatically.
02
📦 Container Ships Become Scarce
Ships are rerouting around the conflict zone. This means fewer vessels on the normal China-India trade routes. Container availability drops. Shipping lines impose war-risk surcharges of $4,000 to $8,000 per shipment. Insurance costs for cargo also spike. All these costs land on India’s pharma importers.
03
⚗️ Crude Oil Prices Push Up Solvent Costs
Pharmaceutical solvents are made from petrochemicals — directly derived from crude oil. When crude prices cross $100 per barrel, solvent prices also rise. Industry expert Mehul Shah told the Economic Times that pharma solvents rose 20–30% within a single week. Solvents are a direct production input. So every tablet and capsule made in India now costs more to produce.
04
🏭 Importers Pass Costs to Pharma Companies
Raw material importers are absorbing some costs. However, they cannot absorb all of it. They begin passing the increase to pharma manufacturers. Drug makers are squeezed — their input costs rise, but they cannot raise medicine prices freely because of NPPA regulation. So profits fall sharply. Smaller companies face serious financial strain.
05
💰 If Crisis Continues — Prices Rise for Patients ⭐
The industry has asked the government to allow an emergency price increase above the normal NPPA cap. The Pharma Entrepreneurs Federation has formally requested the NPPA to apply Para 19 of the Drug Price Control Order 2013 — a provision for crisis situations. If approved, regulated medicine prices can be revised upward. That means patients directly feel the impact in their medicine bills.
💡 The Chain: Iran War → Strait Disrupted → Shipping Costs Double → Solvent & API Costs Rise 30–64% → Pharma Margins Squeezed → Industry Requests Price Hike → Patients May Pay More.
💉 Medicine Impact
Which Medicines Are Most at Risk of Price Rise?
Not all medicines are equally affected. Some are at immediate risk. Others may be affected only if the conflict continues for weeks. Here is the complete breakdown — organised by risk level.
| Medicine Type | Risk Level | Examples | Why Affected |
|---|
| Vitamins & Supplements | 🔴 Very High | Vitamin C, Vitamin B12, Vitamin D, Multivitamins | APIs mostly imported from China; glycerine up 64% |
| Antibiotics | 🔴 Very High | Amoxicillin, Azithromycin, Ciprofloxacin | Key raw materials from China disrupted; shipping delays |
| Painkillers | 🔴 High | Paracetamol, Ibuprofen, Diclofenac | Paracetamol base has already spiked; solvent costs rising |
| Blood Pressure Medicines | 🟡 Medium | Amlodipine, Telmisartan, Losartan | Long-term API supply at risk if disruption continues |
| Diabetes Medicines | 🟡 Medium | Metformin, Glibenclamide, Insulin | Medium-term risk; cold-chain shipment disruptions |
| Cancer Medicines | 🟡 Medium | Various oncology drugs | Temperature-sensitive; cold-chain logistics at risk |
| Generic Branded Medicines ✅ | 🟢 Lower Risk (for now) | Jan Aushadhi medicines, DPCO regulated drugs | Government buffer stocks and regulated supply help insulate |
📈 Key Raw Material Price Increases
| Raw Material | Price Change | Used In |
|---|
| Glycerine | +64% | Cough syrups, skincare medicines, suppositories |
| Pharmaceutical Solvents | +20–30% | Almost all tablet and capsule manufacturing |
| Paracetamol Base | Sharp spike | Crocin, Dolo, Paracetamol IP tablets |
| General APIs from China | +30% average | Antibiotics, vitamins, blood pressure medicines |
💡 What This Means for You: If you take daily medicines for blood pressure, diabetes, or other chronic conditions, consider stocking up for 2–3 months at current prices. However, do not panic-buy — shortages only get worse when everyone buys in bulk simultaneously.
📋 NPPA Rules — Can Medicine Prices Actually Rise in India?
India has one of the strongest drug price control systems in the world. The NPPA controls prices of over 800 essential medicines. This list covers most common drugs Indians use daily. Companies cannot raise prices of these medicines freely.
So will your medicines really get costlier? The answer depends on whether the NPPA allows an emergency revision.
✅ Medicines That Are Protected (For Now)
All medicines listed under the National List of Essential Medicines have NPPA-controlled prices. These include most antibiotics, painkillers, blood pressure medicines, diabetes drugs, and vitamins. Companies cannot raise prices beyond the annual allowed ceiling without specific government approval.
❌ The Industry Is Already Requesting an Emergency Hike
The Pharma Entrepreneurs Federation has formally asked the NPPA to invoke Para 19 of the Drug Price Control Order (DPCO) 2013. This provision allows emergency price revisions in crisis situations. If the government agrees, essential medicine prices can go up — even the ones normally controlled. The industry says it cannot absorb the unprecedented input cost increases any longer.
⚠️ Non-Essential Medicines Can Already Rise
Medicines not covered by NPPA price control — such as branded supplements, OTC health products, cosmetic creams, and some specialty medicines — are not regulated. Manufacturers can raise prices on these freely. Expect these to get costlier first, before any government action on essential medicines.
💡 Bottom Line on NPPA: Government-regulated essential medicines are protected for now. However, the pharma industry is actively lobbying for price increases. If the Iran conflict continues beyond 2–3 more weeks, price revisions on essential medicines may become unavoidable.
📦 India’s Pharma Exports — ₹5,000 Crore at Risk
India is not just affected as a buyer of raw materials. India also sells finished medicines worldwide. The Middle East is a key buyer — and that region is now at war.
Pharmexcil, the Pharma Export Council of India (Pharmexcil), has warned that a total halt to pharma shipments to West Asia for just one month could drain ₹2,500 to ₹5,000 crore in export value. Countries like the UAE, Saudi Arabia, Oman, Kuwait, and Jordan depend heavily on India for affordable generic medicines.
📊 India Pharma Export Facts
- Total pharma exports in FY2024–25: $30.47 billion
- Growth rate: 9.4% year on year
- GCC region share: 5.5% of total exports
- West Asia exports: $1.75 billion in FY25
- India is the largest supplier of generic medicines globally
⚠️ What Is at Risk Now
- Shipping through Gulf routes disrupted
- Insurance premiums on cargo skyrocketing
- Surcharges of $4,000–$8,000 per shipment
- Cold-chain medicines face temperature risks on longer routes
- Export losses of ₹2,500–₹5,000 crore feared
Telangana hosts many of India’s largest pharma companies — including global players in Hyderabad’s bulk drug hub. These companies export medicines to the Middle East, the USA, and Europe. Furthermore, Andhra Pradesh also has a growing pharma manufacturing base. Both states are now bracing for significant financial impact.
However, not everyone is alarmed. According to a Pharmexcil source, some companies are already pivoting to find alternative buyers in the US and European markets. Companies with diversified export portfolios are better placed to absorb the shock.
🚫 Mistakes to Avoid During This Crisis
❌ Don’t Panic-Buy Medicines
Hoarding medicines makes the shortage worse for everyone. Chemists face empty shelves. Patients who genuinely need medicines cannot find them. Buy only what you need for 4–8 weeks at most. Avoid clearing out chemist shelves.
❌ Don’t Switch Brands Without a Doctor’s Advice
In a shortage, some people switch to different brands of the same medicine. This can be risky for critical medications. Always consult your doctor before switching. Different brands may have slightly different bioavailability or inactive ingredients that affect you.
❌ Don’t Stop Your Medication Suddenly
If your medicine seems costlier or hard to find, don’t stop taking it suddenly. Stopping blood pressure, diabetes, or psychiatric medications abruptly is dangerous. Instead, talk to your doctor about alternatives or generic substitutes immediately.
❌ Don’t Pay Black Market Prices
If a medicine gets scarce, some sellers charge above MRP. That is illegal. This is illegal in India. Always check the printed MRP on the medicine pack. You can also check NPPA’s official website for the notified maximum price of any medicine.
🏛️ Government Response — What Steps Are Being Taken?
The government has been watching the situation closely. Several steps are either underway or under consideration.
✅ Monitoring API Stock Levels
The Ministry of Pharmaceuticals is monitoring API stocks and production levels at major manufacturers. This helps spot shortages early. Bulk drug parks in AP and Himachal Pradesh are also being fast-tracked to make more APIs locally.
✅ Jan Aushadhi Scheme — Government Generic Medicines
The PM Jan Aushadhi Yojana sells generic medicines at 50–80% below market prices through government-run outlets. In a crisis, these stores give you an affordable option. If you don’t already know your nearest Jan Aushadhi store, now is the time to find one.
⏳ NPPA Emergency Price Revision — Decision Pending
The pharma industry has formally requested the NPPA to invoke the emergency clause of DPCO 2013. The government has not yet made a decision. A revision would allow price increases for regulated essential medicines. Meanwhile, the NPPA is likely weighing the impact on millions of patients across India.
✅ Diversifying Oil and Gas Imports — Reduces Indirect Pressure
India is also diversifying its crude oil and LPG imports to reduce dependence on Middle East routes. This helps stabilise petrochemical prices — which directly feed into pharmaceutical solvent costs. Canada has offered an LPG supply deal, and India is in discussions to diversify further.
✅ What Should You Do Right Now — Practical Action Plan
01
If You Take Daily Medicines — Stock Up Sensibly
If you have a chronic condition — diabetes, blood pressure, thyroid, heart disease — buy 6–8 weeks of your medicines now at current prices. This gives you a buffer. However, do not buy more than 2–3 months — that wastes money and creates artificial shortages for others.
02
Ask Your Doctor About Generic Alternatives
Most branded medicines have equally effective generic versions. Generic medicines use the same active ingredient but cost significantly less. Ask your doctor to prescribe by generic name — not by brand. This also protects you if one specific brand faces a supply issue.
03
Find Your Nearest Jan Aushadhi Store
The PM Jan Aushadhi Yojana offers essential medicines at 50–80% less than market price. These stores are present across India — including in Andhra Pradesh, Telangana, and most tier-2 cities. Visit janaushadhi.gov.in to find the nearest outlet. These stores are a lifeline if branded medicines become expensive.
04
Check Medicine Prices on NPPA Website
If your chemist charges above the printed MRP, that is illegal. Furthermore, you can verify the official maximum retail price of any regulated medicine at nppaindia.nic.in. If a chemist overcharges you, file a complaint with the district drug control office immediately.
05
Stay Informed — Monitor Government Announcements ⭐
The NPPA emergency price revision decision is still pending. Follow BeInCareer and official government sources for updates. If the NPPA allows a price revision, we will cover it immediately. Additionally, the Ministry of Health is expected to release official guidance on API stock levels soon.
💬 Frequently Asked Questions — Iran War & Medicine Prices India
Will medicine prices rise in India because of the Iran war?
Yes, there is a strong risk. Pharma raw material costs have already risen 30–64%. Shipping costs have doubled. Pharmaceutical solvents are up 20–30%. For now, NPPA rules protect essential medicine prices. However, the pharma industry has formally asked the government to allow emergency price increases. If approved, medicine prices will rise — especially vitamins, antibiotics, and painkillers.
Which medicines are most likely to get costlier in India?
Vitamins and supplements face the highest risk because their APIs come mostly from China through disrupted routes. Antibiotics like Amoxicillin and Azithromycin are also at high risk. Painkillers like Paracetamol and Ibuprofen are already seeing input cost spikes. Blood pressure and diabetes medicines face medium-term risk if the conflict continues for weeks.
What is an API and why does India import it from China?
API stands for drug ingredient — the core chemical compound that makes a medicine work. India imports most of its APIs from China because China produces them at very low cost due to large-scale manufacturing and lower input costs. India then uses these APIs to manufacture finished medicines — both for domestic use and for export worldwide. This reliance on China is a key weakness right now.
Can the government stop medicine prices from rising?
The government controls prices of over 800 essential medicines through the NPPA. For now, these prices are protected. However, the pharma industry is requesting the NPPA to invoke an emergency clause that would allow price hikes above the normal ceiling. If the government agrees, regulated medicine prices can rise. If the government refuses, pharma companies will absorb losses — but supply may become unreliable.
What is the Jan Aushadhi Yojana and how does it help?
PM Jan Aushadhi Yojana is a government scheme that sells high-quality generic medicines at 50–80% less than branded market prices. These medicines use the same active ingredients as expensive branded drugs. The scheme has over 10,000 outlets across India. During a price crisis, Jan Aushadhi stores are the most affordable and reliable option for patients. Visit janaushadhi.gov.in to find your nearest store.
Is it safe to buy medicines from online pharmacies during this crisis?
Yes — from registered, licensed platforms. Always buy from CDSCO-licensed pharmacies or well-known platforms like PharmEasy, Netmeds, or 1mg. Avoid unverified sellers on social media or messaging apps. In a shortage, fake or substandard medicines enter the market. Stick to trusted sources and always check the MRP printed on the pack before buying.
📚 Related Articles on BeInCareer
Connect with BeInCareer
Latest news · Career tips · Job alerts · Finance guides
© BeInCareer 2026 • Updated March 12, 2026 • beincareer.com
